DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA Technologies
January 18, 2021
Mammoth Biosciences will apply its DETECTR™ platform, and IDbyDNA its proprietary pathogen database and algorithms, toward the development of CRISPR-based diagnostics and biosurveillance technologies against infectious disease threats for the U.S. Department of Defense (DoD). [Source: MR.Cole Photographer / Moment / Getty Images]
Share
Mammoth Biosciences will apply its DETECTR™ platform, and IDbyDNA, its proprietary pathogen database and algorithms, toward the development of CRISPR-based diagnostics and biosurveillance technologies against varied disease threats for the U.S. Department of Defense (DoD).
Mammoth and IDbyDNA are among subcontractors under a four-year, up-to-$36.7 million CRISPR diagnostics contract inked by DoD’s Defense Advanced Research Projects Agency (DARPA) with prime contractor MRIGlobal.